Search results

From WikiAnesthesia
Did you mean: neuromuscular blocker
  • Rocuronium (category Neuromuscular blockers)
    Butterworth IV, John F.; Mackey, David C.; Wasnick, John D. (2022), "Neuromuscular Blocking Agents", Morgan & Mikhail’s Clinical Anesthesiology (7 ed.), New
    2 KB (86 words) - 14:27, 22 December 2022
  • Vecuronium (category Neuromuscular blockers)
    clinical practice Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia
    5 KB (420 words) - 09:10, 5 January 2023
  • Succinylcholine (category Neuromuscular blockers)
    Succinylcholine, also known as suxamethonium, is a short-acting neuromuscular blocker used during intubation. hyperkalemia increased risk of malignant
    2 KB (25 words) - 16:41, 17 July 2022
  • Mivacurium (category Neuromuscular blockers)
    in the United States of America Goodwin, G., Joseph, V. (2015). Neuromuscular Blockers. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology
    6 KB (503 words) - 09:28, 5 January 2023
  • Brachial plexus blocks Interscalene block Supraclavicular block Infraclavicular block Axillary block Digital block Wrist block Intercostal nerve block Pectoralis
    48 KB (3,882 words) - 14:34, 16 August 2023
  • Cisatracurium (category Neuromuscular blockers)
    retrieved 2023-01-05 Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia
    5 KB (449 words) - 14:14, 8 January 2023
  • to nondepolarizing neuromuscular blockers Resistant to succinylcholine At increased risk for developing phase II neuromuscular block, particularly with
    6 KB (544 words) - 04:57, 17 July 2022
  • disease may incite hyperkalemia after administration Non-depolarizing neuromuscular blockers may be prolonged Take caution with regional anesthesia, although
    3 KB (171 words) - 05:51, 14 June 2023
  • In those patients who are heterozygous for Asp70Gly, the effects of neuromuscular blockade may be prolonged three to eight times that of normal3. In those
    18 KB (2,664 words) - 19:49, 4 October 2022
  • Sugammadex (category Neuromuscular blocker reversal agents)
    Sugammadex Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium. If a patient requires reparaylsis after administration
    3 KB (161 words) - 00:34, 30 March 2022
  • reaction, not anaphylaxis Allergic reactions are more likely from neuromuscular blockers than antibiotics From Vaisman, et al. JAMA 2017 Patients at increased
    10 KB (1,348 words) - 11:29, 1 September 2023
  • preferred for rapid emergence to facilitate early neuro exam. Patient neuromuscularly blocked throughout to reduce risk of inadvertent injury. No neuromonitoring
    4 KB (82 words) - 17:59, 31 July 2022
  • Neuromuscular blockade involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical
    8 KB (1,025 words) - 04:45, 4 July 2022
  • Clinical data Drug class Neuromuscular blocker Routes of administration Intravenous Dosage Pharmacodynamics Mechanism of action Nicotinic acetylcholine
    1 KB (9 words) - 00:32, 30 March 2022
  • Clinical data Drug class Neuromuscular blocker Dosage Pharmacodynamics Mechanism of action Nicotinic acetylcholine antagonism Pharmacokinetics Physical
    1 KB (9 words) - 00:33, 30 March 2022
  • (low albumin level), and increased sensitivity. Non depolarizing neuromuscular blocking agents should be chosen with patients organ function in mind. Often
    24 KB (969 words) - 22:28, 14 January 2024
  • ketamine, or dexmedetomidine with a longer acting nondepolarizing neuromuscular blocker infusion. Tend to avoid propofol due to risk of interfering with
    7 KB (731 words) - 12:21, 4 May 2024
  • File:Suggested reading neuro ABR.pdf (matches file content)
    Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor. Anesth Analg. 2002
    (1,275 × 1,650 (33 KB)) - 00:36, 17 May 2022
  • File:Awake Fiberoptic Intubation 2018 6 (002).pdf (matches file content)
    using appropriate anesthetic agents (intravenous, inhalational, neuromuscular blockers). 3
    (1,275 × 1,650 (14 KB)) - 00:41, 17 May 2022
  • File:Goligher Anesthesiology 2017 - Synchrony and MV.pdf (matches file content)
    Guérin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;
    (1,218 × 1,631 (186 KB)) - 00:42, 17 May 2022
  • 1 member (0 subcategories, 0 files) - 09:18, 20 February 2021
  • File:Dres Intensive Care Med 2017 - Critical Illness Diaphragm Atrophy.pdf (matches file content)
    guided by judicious evaluation of expected benefits and harm. While neuromuscular blockers are used to adapt patients to the ventilator, they render the diaphragm
    (1,275 × 1,650 (3.54 MB)) - 00:42, 17 May 2022
  • File:Shaydenfish et al reversal AnesthAnalg 2019.pdf (matches file content)
    primary hypothesis that neuromuscular blocking drug reversal with neostigmine and glycopyrrolate versus no neuromuscular blocking drug reversal is associated
    (1,218 × 1,631 (373 KB)) - 00:42, 17 May 2022
  • File:Gattinoni AMA 2018 - Re-think approach to ARDS.pdf (matches file content)
    Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116
    (1,275 × 1,650 (110 KB)) - 00:40, 17 May 2022
  • File:Residual neuromuscular blockade and paralysis and negative perioperative outcomes -review- (Farhan 2014).pdf (matches file content)
    paralysis such as neuromuscular transmission monitoring and judicious use of low-dose neuromuscular blocking drugs. Neuromuscular blocking agent effects should
    (1,240 × 1,647 (616 KB)) - 00:32, 17 May 2022
  • File:Intraoperative neuromuscular monitoring site and residual paralysis (Thilen 2012).pdf (matches file content)
    intense neuromuscular block. Anesth Analg 1994; 78:697-700 13. Rimaniol JM, Dhonneur G, Sperry L, Duvaldestin P: A comparison of the neuromuscular blocking
    (1,218 × 1,631 (490 KB)) - 00:31, 17 May 2022
  • gastric decompression prior to insufflation, if laparoscopic. Maintain neuromuscular blockade with ToF assessment. If the patient has an epidural catheter
    6 KB (793 words) - 12:43, 22 September 2022
  • for reversal of neuromuscular blockade in order to reduce their muscarinic effects. Treatment of bradycardia (vasovagal response, AV block, bradyarrhythmias)
    6 KB (510 words) - 18:18, 10 January 2024
  • File:Obstetric Anesthesia CA1 Lecture 05Feb21.pdf (matches file content)
    volatile anesthetics • Increased sensitivity of nondepolarizing neuromuscular blockers • Increased risk of pulmonary edema 8-12 mEq/L • Loss of deep tendon
    (1,500 × 843 (1.41 MB)) - 00:35, 17 May 2022
  • File:Brochard PSILI.pdf (matches file content)
    JM, Perez D, Seghboyan JM, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:
    (1,218 × 1,631 (581 KB)) - 00:37, 17 May 2022
  • File:Sottile ATS 2017 - Cisatracurium vs Vecuronium.pdf (matches file content)
    VASOPRESSOR DAYS PRIOR TO NEUROMUSCULAR BLOCKADE RENAL FAILURE DATS PRIOR TO NEUROMUSCULAR BLOCKADE DAYS FROM VENTILATION TO NEUROMUSCULAR BLOCKADE PROPENSITY
    (1,275 × 1,650 (605 KB)) - 00:38, 17 May 2022
  • File:Ruscic 2017 Curr Opin Anes - Respiratory Complications.pdf (matches file content)
    neostigmine reversal using neuromuscular transmission monitoring. 32. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for
    (1,222 × 1,629 (757 KB)) - 00:42, 17 May 2022
  • File:Obstetric Anesthesia Review for the Basic Boards 08May18.pdf (matches file content)
    following regional nerve blocks except a. b. c. d. e. Paracervical block Saddle block Lumbar epidural block Pudendal block Caudal block Somatic pain associated
    (1,500 × 843 (1.23 MB)) - 00:33, 17 May 2022
  • File:CSI Checklist 2020.pdf (matches file content)
    Workstation principles ☐ Emergency push medications: ☐ Vasopressor ☐ Rapid Neuromuscular blocker ☐ Induction agent ☐ Laryngoscopes ☐ Oral airway ☐ Endotracheal Tube
    (1,275 × 1,650 (78 KB)) - 00:34, 17 May 2022
  • File:APFS Startup Checklist .pdf (matches file content)
    to complete the startup-test as safely as possible. 1) Administer neuromuscular blocker and/or sedation to prevent patient coughing 2) Have ready, a metal
    (1,275 × 1,650 (131 KB)) - 00:38, 17 May 2022
  • File:Anaphylaxis Advanced Topics in Anesthesia March 2018.pdf (matches file content)
    and Interventions IV. Causes of Anaphylaxis A. Neuromuscular blocking drugs Neuromuscular blocking drugs (NMBDs) have long been considered the most common
    (1,275 × 1,650 (167 KB)) - 00:30, 17 May 2022
  • (primarily class 1A and 1C antiarrhythmics) Sugammadex should be used for neuromuscular blockade reversal Manage arrhythmic storm with defibrillation, isoprotenerol
    19 KB (2,301 words) - 23:40, 11 November 2022
  • premedication. Superficial cervical plexus blocks + supplemental field blocks by surgeon Deep cervical plexus blocks are now avoided due to concomitant Horner's
    13 KB (1,149 words) - 17:50, 21 July 2022
  • Most common anesthesia type is general anesthesia May need to reverse neuromuscular blockade if neuromonitoring is used If neuraxial anesthesia is chosen
    11 KB (878 words) - 22:45, 21 February 2022
  • File:Breastfeeding.pdf (matches file content)
    Vitamins in Nitrous Oxide trial, serial IV = intravenous; NMBAs = neuromuscular blocking agents. postoperative 12-lead ECG were obtained from 469 patients
    (1,218 × 1,631 (351 KB)) - 10:51, 26 July 2021
  • File:ART Investigators Am Med Assoc 2017 - Rm and survival in ards.pdf (matches file content)
    not significantly different after day 1. Cointerventions Use of neuromuscular blockers was higher in the experimental than the control group (96.8% vs
    (1,275 × 1,650 (442 KB)) - 00:32, 17 May 2022
  • File:Lele J of Clinical Anes 2013 - Severe hypothyroidism myxedema coma in post op period.pdf (matches file content)
    metabolic derangements, and drug interactions with calcium channel blockers, beta-blockers, angiotensin-converting enzyme inhibitors, and 5HT-3 agents. Caution
    (1,237 × 1,650 (105 KB)) - 00:34, 17 May 2022

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)